ArticleBiology2021

Influence of Performance Status on the Effectiveness of Pembrolizumab Monotherapy in First-Line for Advanced Non-Small-Cell Lung Cancer: Results in a Real-World Population.

Rocío Jiménez Galán et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.